Monoceros Biosystems is a biotechnology startup founded in 2017 with a focus on making top quality bioinformatics available to all. The company specializes in applications of bioinformatics, genomics, and data mining technologies in drug discovery and boasts expertise in small molecule, antibody, and oligonucleotide target identification and validation. Additionally, Monoceros Biosystems is involved in the discovery of novel pharmacodynamic, diagnostic, prognostic biomarkers and patient selection strategies within the Biotechnology and Pharmaceutical industries. The precise location of their headquarters and their latest investment details are not available at the moment. However, the company's slogan "Making top quality bioinformatics available to all" presents a clear commitment to accessibility and innovation in the field of bioinformatics.
There is no investment information
No recent news or press coverage available for Monoceros Biosystems.